Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax or 2)80-85% HRmax 4 times per week. The primary objective is to test whether the progression of the signs of Parkinson's disease is attenuated at 12 months in among persons who have not initiated medication for Parkinson Disease (PD) when they perform high-intensity endurance treadmill exercise.
Auricular Muscle Zone Stimulation for Parkinson Disease (Earstim-PD)
A Multicenter, Randomized, Blinded, Electronic Device in Subjects with Parkison Disease.
Parkinson's Foundation PD GENEration Genetic Registry
Development of a central repository for PD-related genomic data for future research.
100 Clinical Results associated with Parkinson Study Group
0 Patents (Medical) associated with Parkinson Study Group
100 Deals associated with Parkinson Study Group
100 Translational Medicine associated with Parkinson Study Group